152 related articles for article (PubMed ID: 38757190)
1. Looking back, moving forward: protein corona of lipid nanoparticles.
Gao Y; Huang Y; Ren C; Chou P; Wu C; Pan X; Quan G; Huang Z
J Mater Chem B; 2024 Jun; 12(23):5573-5588. PubMed ID: 38757190
[TBL] [Abstract][Full Text] [Related]
2. Research progress and application opportunities of nanoparticle-protein corona complexes.
Huang W; Xiao G; Zhang Y; Min W
Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
[TBL] [Abstract][Full Text] [Related]
3. The role of surface chemistry in serum protein corona-mediated cellular delivery and gene silencing with lipid nanoparticles.
Chen D; Ganesh S; Wang W; Amiji M
Nanoscale; 2019 May; 11(18):8760-8775. PubMed ID: 30793730
[TBL] [Abstract][Full Text] [Related]
4. The effects of protein corona on in vivo fate of nanocarriers.
Xiao Q; Zoulikha M; Qiu M; Teng C; Lin C; Li X; Sallam MA; Xu Q; He W
Adv Drug Deliv Rev; 2022 Jul; 186():114356. PubMed ID: 35595022
[TBL] [Abstract][Full Text] [Related]
5. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
Moraru C; Mincea M; Menghiu G; Ostafe V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
[TBL] [Abstract][Full Text] [Related]
6. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
Liu N; Tang M; Ding J
Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
[TBL] [Abstract][Full Text] [Related]
7. The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.
Francia V; Schiffelers RM; Cullis PR; Witzigmann D
Bioconjug Chem; 2020 Sep; 31(9):2046-2059. PubMed ID: 32786370
[TBL] [Abstract][Full Text] [Related]
8. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
Shang L; Nienhaus GU
Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
[TBL] [Abstract][Full Text] [Related]
9. Engineering the protein corona: Strategies, effects, and future directions in nanoparticle therapeutics.
Zhao T; Ren M; Shi J; Wang H; Bai J; Du W; Xiang B
Biomed Pharmacother; 2024 Jun; 175():116627. PubMed ID: 38653112
[TBL] [Abstract][Full Text] [Related]
10. Interaction Kinetics of Individual mRNA-Containing Lipid Nanoparticles with an Endosomal Membrane Mimic: Dependence on pH, Protein Corona Formation, and Lipoprotein Depletion.
Aliakbarinodehi N; Gallud A; Mapar M; Wesén E; Heydari S; Jing Y; Emilsson G; Liu K; Sabirsh A; Zhdanov VP; Lindfors L; Esbjörner EK; Höök F
ACS Nano; 2022 Dec; 16(12):20163-20173. PubMed ID: 36511601
[TBL] [Abstract][Full Text] [Related]
11. Insights into colloidal nanoparticle-protein corona interactions for nanomedicine applications.
Martínez-Negro M; González-Rubio G; Aicart E; Landfester K; Guerrero-Martínez A; Junquera E
Adv Colloid Interface Sci; 2021 Mar; 289():102366. PubMed ID: 33540289
[TBL] [Abstract][Full Text] [Related]
12. Effect of Lipid Corona on Phenylalanine-Functionalized Gold Nanoparticles to Develop Stable and Corona-Free Systems.
Tabassum H; Maity A; Singh K; Bagchi D; Prasad A; Chakraborty A
Langmuir; 2024 Feb; 40(8):4531-4543. PubMed ID: 38357868
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence correlation spectroscopy as a tool for the study of the intracellular dynamics and biological fate of protein corona.
Martinez-Moro M; Di Silvio D; Moya SE
Biophys Chem; 2019 Oct; 253():106218. PubMed ID: 31325709
[TBL] [Abstract][Full Text] [Related]
14. How Corona Formation Impacts Nanomaterials as Drug Carriers.
Gupta MN; Roy I
Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
[TBL] [Abstract][Full Text] [Related]
15. Understanding the Lipid and Protein Corona Formation on Different Sized Polymeric Nanoparticles.
Lima T; Bernfur K; Vilanova M; Cedervall T
Sci Rep; 2020 Jan; 10(1):1129. PubMed ID: 31980686
[TBL] [Abstract][Full Text] [Related]
16. Biological effects of formation of protein corona onto nanoparticles.
Mishra RK; Ahmad A; Vyawahare A; Alam P; Khan TH; Khan R
Int J Biol Macromol; 2021 Apr; 175():1-18. PubMed ID: 33508360
[TBL] [Abstract][Full Text] [Related]
17. Effects of the protein corona on liposome-liposome and liposome-cell interactions.
Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Sherman MB; Parodi A; Salvatore F; Tasciotti E
Int J Nanomedicine; 2016; 11():3049-63. PubMed ID: 27445473
[TBL] [Abstract][Full Text] [Related]
18. The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study.
Hadjidemetriou M; McAdam S; Garner G; Thackeray C; Knight D; Smith D; Al-Ahmady Z; Mazza M; Rogan J; Clamp A; Kostarelos K
Adv Mater; 2019 Jan; 31(4):e1803335. PubMed ID: 30488990
[TBL] [Abstract][Full Text] [Related]
19. A magnetic separation method for isolating and characterizing the biomolecular corona of lipid nanoparticles.
Francia V; Zhang Y; Cheng MHY; Schiffelers RM; Witzigmann D; Cullis PR
Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307803120. PubMed ID: 38437542
[TBL] [Abstract][Full Text] [Related]
20. Potential clinical applications of the personalized, disease-specific protein corona on nanoparticles.
García Vence M; Chantada-Vázquez MDP; Vázquez-Estévez S; Manuel Cameselle-Teijeiro J; Bravo SB; Núñez C
Clin Chim Acta; 2020 Feb; 501():102-111. PubMed ID: 31678275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
